In line with the government’s vision of affordable and accessible healthcare for all, it would be worthwhile for public and private players to come together and work on a roadmap to resolve some of these teething issues. Siddharth Gadia and Girish Agarwal, Founders, Generico, give an insight
62-YEAR-OLD BHAGAT (name changed upon patient’s request) from Mumbai, suffers from a cardiovascular condition. He underwent his first angioplasty in 2016 after which surgeries followed in 2017 and 2018. Along with the surgical procedures, Bhagat was advised regular medication which added to his already surmounting healthcare-related expenditure.
During one of his regular visits to the doctor, Bhagat encountered a fellow patient who informed him about generic medicines, which were a far more affordable option for a chronic disease patient like him. He consulted his doctor and soon afterwards switched to generic medications. His monthly expenses towards medicines reduced dramatically, from 2,000 a month to 700 a month.
Several months have passed since Bhagat has been on generic medicines and emphasises that his health parameters continue to be the same as when he was taking branded medicines. He insists that he took this decision of switching to generic medicines with complete trust on his doctor’s advice. After changing to generic generics, he has experienced 65 per cent increase in his monthly savings.
Millions of patients like Bhagat, living with chronic and noncommunicable diseases (NCDs) have to bear medical expenses throughout their life, post diagnosis. India’s burden of NCDs is only growing manifold, year-on-year. The onset of NCDs in India occurs typically a decade earlier than many developed countries, with the average age threshold being 45 years, thereby impacting a majority of the country’s productive workforce. Of all the NCDs, cardiovascular diseases, diabetes, respiratory diseases, cancer and hypertension, account for 60 per cent of all mortality in the country.
هذه القصة مأخوذة من طبعة February 16-28, 2019 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك ? تسجيل الدخول
هذه القصة مأخوذة من طبعة February 16-28, 2019 من Express Pharma.
ابدأ النسخة التجريبية المجانية من Magzter GOLD لمدة 7 أيام للوصول إلى آلاف القصص المتميزة المنسقة وأكثر من 9,000 مجلة وصحيفة.
بالفعل مشترك? تسجيل الدخول
Powerful Process Control with IND500x Weighing Indicators
Ensuring consistent quality in hazardous environments, particularly in Ex-Areas (Zone 1/21, Division 1), is a critical aspect of industrial operations. The IND500x weighing indicators from METTLER TOLEDO provide a robust solution for these challenging settings, offering optimized safety and productivity.
Ensuring clean room integrity with prime clean reset high-speed doors
Prime Clean Reset high-speed doors ensure airtight seals, minimising air permeability and contamination in clean rooms. Designed for sensitive environments, they enhance operational efficiency and meet rigorous regulatory standards, making them ideal for pharmaceutical and biotech industries
Complete environmental monitoring solution - testo Saveris Pharma
There are several critical applications in the industry like research and development that demand for continuous & reliable monitoring of important environmental parameters.
Adaptive Manufacturing:-The new flexibility in medical device assembly
Unlike traditional, rigid production lines, B&R's adaptive machines seamlessly adjust to the requirements of each device, dynamically adapting to each unique process
Reshaping pharma safety with active packaging innovations
CILICANT is revolutionising active packaging with solutions tailored for the most sensitive formulations. Meet the innovators driving stability, safety, and impurity control in pharma packaging at CPhI India
UNLOCKING GROWTH FRONTIERS
Vadodara Pharma Summit 2024 brought together industry leaders and experts to highlight the city's pivotal role in India's pharma landscape and explore collaborative strategies to strengthen India's pharma innovation ecosystem
Optimising cloud provisioning for pharmaceutical compliance and operational excellence
Suresh Perikala, Senior Engineering Lead - DevOps and Cloud Engineering Practice, Altimetrik
Accelerating pharma's sustainability efforts
Avinaw Prasad, Director, Climate Change & Sustainability, Deloitte India explains why integrating sustainability into the core pharma business strategy is essential for long-term success, analyses key focus areas and policy pushes which can incentivise companies to further evolve on the sustainability path
Drug Repurposing: Unlocking access to rare solutions
Drug repurposing, a quick, cost-effective path to deliver existing treatments to patients, can serve to expedite and expand healthcare access for patients with rare diseases
Optimising spend, maximising growth
Express Pharma, in partnership with IPA and CHEMEXCIL, powered by SAP, recently organised a thought leadership conclave on 'Reimagining spend management and supply chain' where cross functional experts explored strategies to drive value through supply chain transformation